![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (197)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Abdelbaset A Elzagallaai & Michael J Rieder. (2023) Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions. Expert Review of Clinical Pharmacology 16:12, pages 1187-1199.
Read now
Read now
Pungki Afifah Asyraf, Ivanna Fauziyah Kusnadi, Jonathan Stefanus, Miski Aghnia Khairinisa & Rizky Abdulah. (2022) Clinical Manifestations and Genetic Influences in Sulfonamide-Induced Hypersensitivity. Drug, Healthcare and Patient Safety 14, pages 113-124.
Read now
Read now
Ahmed Salih Khudhur, Giovanni Di Zenzo & Marco Carrozzo. (2014) Oral lichenoid tissue reactions: diagnosis and classification. Expert Review of Molecular Diagnostics 14:2, pages 169-184.
Read now
Read now
Winnie Ng & Jack Uetrecht. (2013) Changes in gene expression induced by aromatic amine drugs: Testing the danger hypothesis. Journal of Immunotoxicology 10:2, pages 178-191.
Read now
Read now
Maja Mockenhaupt. (2012) Allopurinol is the most frequent cause of Stevens–Johnson syndrome and toxic epidermal necrolysis. Expert Review of Dermatology 7:3, pages 213-215.
Read now
Read now
Articles from other publishers (192)
Jennifer Caudill, Tim Chrisman, Joanna Chen, Kelsee Zajac & Richard Simman. (2023) Differential diagnosis of stage 2, 3 and 4 pressure injuries of the pelvis and lower extremity: a case series. Journal of Wound Care 32:Sup9, pages S22-S36.
Crossref
Crossref
Tiberiu Paul Neagu, Mirela Tiglis, Ileana Peride & Andrei Niculae. (2023) Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report. Healthcare 11:15, pages 2195.
Crossref
Crossref
Dayan J. Li, Gustavo A. Velasquez, George A. Romar, Elisa M. Schunkert, Ruth K. Foreman & Sherrie J. Divito. (2023) Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. JAMA Dermatology 159:8, pages 830.
Crossref
Crossref
Preema Sinha, Juhi Sharma, GB Prashantha, Sharanjit Singh ToorParul Kamboj. (2023) Toxic epidermal necrolysis predominantly involving irradiated site in a carcinoma breast patient – An example of immunocompromised cutaneous district. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-3.
Crossref
Crossref
Christian J. Coulson & Marie Yrastorza-Daghman. (2023) Aripiprazole-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Study. Clinical Neuropharmacology 46:4, pages 153-156.
Crossref
Crossref
Noah J Spillers, Patrick M Luther, Norris C Talbot, Gianni H Ly, Evan M Downs, Gabriel Lavespere, Denisa Pavlickova, Shahab Ahmadzadeh, Omar Viswanath, Giustino Varrassi, Sahar Shekoohi & Alan D Kaye. (2023) Association of Acetaminophen With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Pharmacologic Considerations and Treatment Options. Cureus.
Crossref
Crossref
Blake Jeffrey McKinley, Mitchell Edger Allen & Nicole Michels. (2023) Photodistributed Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification. European Journal of Medical Research 28:1.
Crossref
Crossref
Mohamed Zakee Mohamed Jiffry, Felipe Carmona Pires, Maria A Perozo, Napat Rangsipat & Daniel Tabares. (2023) A Rare Case of Pertuzumab-Induced Toxic Epidermal Necrolysis. Cureus.
Crossref
Crossref
Gábor Tóth, Andrea Lukács, Frank Schirra, Gábor L. Sándor, Petra Killik, Otto A. Maneschg, Zoltán Z. Nagy & Nóra Szentmáry. (2023) Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review. Ophthalmology and Therapy.
Crossref
Crossref
Yuki Miyamoto, Hiroyuki Ohbe, Ryosuke Kumazawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga & Bon Ohta. (2023) Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatology 159:5, pages 481.
Crossref
Crossref
Erika Yue Lee, Christopher Knox & Elizabeth Jane Phillips. (2023) Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. JAMA Dermatology 159:4, pages 384.
Crossref
Crossref
Emmy N. Nokaneng. (2023) Lip synechiae: A sequelae of carbamazepine‐induced erythema multiforme. A case report and review of current perspectives and controversies. Oral Surgery.
Crossref
Crossref
Shankargouda Patil, Samar Saeed Khan, Jagadish Hosmani, Zafar Ali Khan, Jayanandan Muruganandhan, Shazia Mushtaq, Pradeep Kumar Yadalam, Shilpa Bhandi & Kamran Habib Awan. (2023) Identification of oral immune disorders– A review and a diagnostic algorithm. Disease-a-Month 69:1, pages 101350.
Crossref
Crossref
Gaetano Isola, Simona Santonocito, Rosalia Leonardi & Alessandro PolizziGaetano Isola, Simona Santonocito, Rosalia Leonardi & Alessandro Polizzi. 2023. Oral Lichen Planus and Lichenoid Lesions. Oral Lichen Planus and Lichenoid Lesions
89
186
.
Omar Shareef, James T. Kwan, Sarina Lau, Mohammad Ali Tahboub & Hajirah N. Saeed. (2022) An alternative model for assessing mortality risk in Stevens Johnson syndrome/toxic epidermal necrolysis using a random forests classifier: A pilot study. Frontiers in Medicine 9.
Crossref
Crossref
Yasser H Alnofaiey, Wjood A AlTalhi, Wahaj A Altalhi, Abeer I Alsulaimani & Layla M Alkhaldi. (2022) Steven Johnson Syndrome in a 102-Year-Old Woman in Saudi Arabia: A Case Report. Cureus.
Crossref
Crossref
Lisanne E. N. Manson, Patricia C. Y. Chan, Stefan Böhringer & Henk-Jan Guchelaar. (2022) Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions. Frontiers in Pharmacology 13.
Crossref
Crossref
Xin Zang, Si Chen, Lin Zhang & Yongzhen Zhai. (2022) Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: Case report and literature review. Frontiers in Medicine 9.
Crossref
Crossref
Hua-Ching Chang, Tsung-Jen Wang, Ming-Hsiu Lin & Ting-Jui Chen. (2022) A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. Biomedicines 10:9, pages 2105.
Crossref
Crossref
Ploysyne Rattanakaemakorn, Pasita Palakornkitti, Prinpat Pinyowiwat, Phatphitcha Jedee & Kunlawat Thadanipon. (2022) Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients. Frontiers in Medicine 9.
Crossref
Crossref
Yoko Hirano, Hideyuki Kosumi, Hajime Miyazawa, Teruki Yanagi, Takahiro Hase, Ayame Kimura, Makoto Saito, Takeshi Kondo & Hideyuki Ujiie. (2021) Toxic epidermal necrolysis induced by tirabrutinib. The Journal of Dermatology 49:4.
Crossref
Crossref
Veronique Michaud, Lucy I. Darakjian, Pamela Dow & Jacques Turgeon. (2022) Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis. Current Pharmacology Reports 8:2, pages 79-98.
Crossref
Crossref
S. Zareei, S. H. Nabavizadeh, N. Zareei & R. Abbasi. (2022) A Retrospective Study into Causes and Treatments of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iranian Patients. Journal of Clinical Care and Skills 3:1, pages 19-26.
Crossref
Crossref
Sujaya Manvi, VikramK Mahajan, KaraninderS Mehta, PushpinderS Chauhan, Sanket Vashist, Ravinder Singh & Prabal Kumar. (2022) The clinical characteristics, putative drugs, and optimal management of 62 patients with stevens-johnson syndrome and/or toxic epidermal necrolysis: A retrospective observational study. Indian Dermatology Online Journal 13:1, pages 23.
Crossref
Crossref
Yong Wang, Fangfang Wang, Hongbin Li, Xiaoyuan Hao, Guangping Shen, Yongli Sun & Jing Xia. (2021) Toxic Epidermal Necrolysis Induced by Leflunomide in a Patient With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 27:8S, pages S565-S567.
Crossref
Crossref
Muskaan Sachdeva, Khalad Maliyar & Marisa G. Ponzo. (2021) A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With Biologic for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Journal of Cutaneous Medicine and Surgery 25:6, pages 598-615.
Crossref
Crossref
Gia-Gia Toni Hò, Wiebke Hiemisch, Andreas Pich, Michelle Matern, Lareen Sophi Gräser, Rainer Blasczyk, Christina Bade-Doeding & Gwendolin Sabrina Simper. 2021. New Insights into the Future of Pharmacoepidemiology and Drug Safety. New Insights into the Future of Pharmacoepidemiology and Drug Safety.
Natalia Blanca‐Lopez, Marina Atanaskovic‐Markovic, Eva R. Gomes, Mona Kidon, Semanur Kuyucu, Francesca Mori, Ozge Soyer & Jean‐Christoph Caubet. (2021) An EAACI Task Force report on allergy to beta‐lactams in children: Clinical entities and diagnostic procedures. Pediatric Allergy and Immunology 32:7, pages 1426-1436.
Crossref
Crossref
Max Holtz, Frances Grimstad, Jeannette Higgins, George Denny, Julie Strickland & Tazim Dowlut-McElroy. (2021) Vulvovaginal Involvement in Pediatric Stevens−Johnson Syndrome: A Case Series. Journal of Pediatric and Adolescent Gynecology 34:5, pages 745-748.
Crossref
Crossref
Joseph A Santamaria, Leopoldo C Cancio, Donovan Reed, Hunter Phillips, Sien Chen, Darrel K Carlton & Anthony J Johnson. (2021) Complete Fusion of Both Eyelids in Stevens-Johnson Syndrome: Case Report. Journal of Burn Care & Research 42:5, pages 1023-1025.
Crossref
Crossref
Géza T. TerézhalmyDDS, MADDS, MA, Michaell A. HuberDDSDDS, Lily T. GarcíaDDS, MS, FDDS, MS, F & Ronald L. OcchioneroDDSDDS. 2021. Physical Evaluation and Treatment Planning in Dental Practice. Physical Evaluation and Treatment Planning in Dental Practice
123
175
.
Leah L. Thompson, Steven T. Chen, Andrew Lawton & Alexandra Charrow. (2021) Palliative care in dermatology: A clinical primer, review of the literature, and needs assessment. Journal of the American Academy of Dermatology 85:3, pages 708-717.
Crossref
Crossref
Andrej Cokan, Vida Gavrić Gavrić Lovrec & Iztok Takač. (2021) A Case of Stevens–Johnson Syndrome in Recurrent Late-Stage Ovarian Cancer Patient after Management of Chronic Pain with Elastomeric Pump. Current Oncology 28:4, pages 2928-2932.
Crossref
Crossref
Diego Fernando Hoyos-Samboní, Julián Vicente Munar, David López & Luis Reinel Vásquez-Arteaga. (2021) Síndrome de Stevens-Johnson con reactivación de herpes simple asociado a la ingestión de paracetamol. Reporte de caso. Revista de la Facultad de Medicina 69:4, pages e85264.
Crossref
Crossref
Michael Prodanuk, Hassan Jamal & Janaki Vallipuram. (2021) An adolescent male with respiratory illness and severe mucositis. Paediatrics & Child Health 26:4, pages 200-201.
Crossref
Crossref
Fumi Miyagawa & Hideo Asada. (2021) Chemokines in Severe Cutaneous Adverse Reactions (SCARs). Biomolecules 11:6, pages 847.
Crossref
Crossref
David PudukadanBins John. (2021) Toxic epidermal necrolysis and coronavirus disease 2019: A rare association. Journal of Skin and Sexually Transmitted Diseases 3, pages 184-187.
Crossref
Crossref
Sang-Heon Kim. (2021) Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs. Allergy, Asthma & Immunology Research 13:2, pages 173.
Crossref
Crossref
Tomoyo Oguri, Shinji Sasada, Satoko Shimizu, Risa Shigematsu, Yumi Tsuchiya, Kota Ishioka, Saeko Takahashi, Koichi Oki, Yoshifumi Kimura, Reishi Seki, Shigemichi Hirose & Morio Nakamura. (2021) A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment. Journal of Investigative Medicine High Impact Case Reports 9, pages 232470962110374.
Crossref
Crossref
Sarah Reynolds, Simon Matteus, Manikanta Ajay Krishna Kasina, Damian Roland & Christina Rodriguez-Garcia. (2021) When is a rash not ‘just’ a rash? A guide to recognition and treatment of paediatric dermatological emergencies. Paediatrics and Child Health 31:1, pages 46-54.
Crossref
Crossref
Argyrios Chronopoulos, Maja Mockenhaupt & Uwe Pleyer. 2021. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen
255
275
.
Robert S. Holzman, Thomas J. Mancuso, Joseph P. Cravero & James A. DiNardoRobert S. Holzman. 2021. Pediatric Anesthesiology Review. Pediatric Anesthesiology Review
581
593
.
Deepa Latha Ciddhavaduta, Vivekanandan Kalaiselvan, Madhavi Latha Midde & Deepika Baloju. (2020) Analysis of severity and preventability in patients of—Toxic epidermal necrolysis—A case series. Clinical Case Reports 8:12, pages 2452-2456.
Crossref
Crossref
Zao‐Qian Zheng, Cheng Jiang, Rong‐Liang Yu, Jia‐Qi Zhou, Zheng‐Jia Wu & Jin‐Yu Luo. (2020) General characteristics, economic burden, causative drugs and medical errors associated with medical damage litigation involving severe cutaneous adverse drug reactions in China. Journal of Clinical Pharmacy and Therapeutics 45:5, pages 1087-1097.
Crossref
Crossref
Yi-Tsz Lin, James Chih-Hsin Yang & Chia-Yu Chu. (2020) Esomeprazole-induced Stevens-Johnson syndrome in a patient who underwent nivolumab therapy for advanced lung adenocarcinoma. Lung Cancer 148, pages 177-178.
Crossref
Crossref
Lisanne E. N. Manson, Jesse J. Swen & Henk-Jan Guchelaar. (2020) Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines. Frontiers in Pharmacology 11.
Crossref
Crossref
E.C. Kuijper, L.E. French, C.P. Tensen, M.H. Vermeer & J.N. Bouwes Bavinck. (2020) Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). Journal of the European Academy of Dermatology and Venereology 34:9, pages 1957-1971.
Crossref
Crossref
Natalia Barea‐Jiménez, Javier Calero, Damaris Molina‐Negrón & Lydia M. López Del‐Valle. (2020) Treatment for oral lesions in pediatric patients with Stevens‐Johnson's syndrome: A case report and literature review. International Journal of Paediatric Dentistry 30:4, pages 489-496.
Crossref
Crossref
Wimonchat Tangamornsuksan, Sirikan Chanprasert, Phenphechaya Nadee, Saowalak Rungruang, Natnaree Meesilsat, Mayumi Ueta & Manupat Lohitnavy. (2020) HLA genotypes and cold medicine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Crossref
Lucia Seminario-Vidal, Daniela Kroshinsky, Stephen J. Malachowski, James Sun, Alina Markova, Thomas M. Beachkofsky, Benjamin H. Kaffenberger, Elizabeth N. Ergen, Melissa Mauskar, Alina Bridges, Cody Calhoun, Adela R. Cardones, Steven T. Chen, James Chodosh, Jonathan Cotliar, Mark D.P. Davis, Katherine L. DeNiro, Arturo R. Dominguez, Juliana Eljure-Téllez, Alisa Femia, Lindy P. Fox, Anisha Guda, Caroline Mitchell, Arash Mostaghimi, Alex G. Ortega-Loayza, Cindy Owen, Helena Pasieka, Sahand Rahnama-Moghadam, Hajirah N. Saeed, Rebecca B. Saunderson, Swapna Shanbhag, Victoria R. Sharon, Lindsay Strowd, Samantha Venkatesh, Karolyn A. Wanat, David A. Wetter, Scott Worswick & Robert G. Micheletti. (2020) Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. Journal of the American Academy of Dermatology 82:6, pages 1553-1567.
Crossref
Crossref
Keiko Hikino, Takeshi Ozeki, Masaru Koido, Chikashi Terao, Yoichiro Kamatani, Yoshiko Mizukawa, Tetsuo Shiohara, Mikiko Tohyama, Hiroaki Azukizawa, Michiko Aihara, Hiroyuki Nihara, Eishin Morita, Yoshinori Murakami, Michiaki Kubo & Taisei Mushiroda. (2019)
HLA‐B*51:01
and
CYP2C9*3
Are Risk Factors for Phenytoin‐Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project
. Clinical Pharmacology & Therapeutics 107:5, pages 1170-1178.
Crossref
Crossref
Mojtaba Kamali Aghdam, Akefeh Ahmadiafshar & Kambiz Eftekhari. (2020) Toxic Epidermal Necrolysis Syndrome Following Single-Dose Diclofenac Suppository, A Case Report. Journal of Comprehensive Pediatrics 11:2.
Crossref
Crossref
Cristina Scavone, Cristina Di Mauro, Rosanna Ruggiero, Francesca Futura Bernardi, Ugo Trama, Maria Luisa Aiezza, Concetta Rafaniello & Annalisa Capuano. (2019) Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy. Drugs - Real World Outcomes 7:1, pages 41-51.
Crossref
Crossref
Han Y. Yin, Nicholas Hadjokas, Kanish Mirchia, Robert Swan & Samuel Alpert. (2020) Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome. Case Reports in Ophthalmological Medicine 2020, pages 1-5.
Crossref
Crossref
Marcella P. Medeiros, Caroline H. C. Carvalho, Cláudia G. Santi & Joao Avancini. (2019) Stevens‐Johnson syndrome and toxic epidermal necrolysis – retrospective review of cases in a high complexity hospital in Brazil. International Journal of Dermatology 59:2, pages 191-196.
Crossref
Crossref
Min-Suk Yang, Jin Yong Lee, Jayeun Kim, Gun-Woo Kim, Byung-Keun Kim, Ju Young Kim, Heung-Woo Park, Sang-Heon Cho, Kyung-Up Min & Hye-Ryun Kang. (2020) Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea. The Journal of Allergy and Clinical Immunology: In Practice 8:2, pages 690-695.e2.
Crossref
Crossref
Marcia Ramos-e-Silva, Pedro Secchin & Beatriz Trope. (2020) The life-threatening eruption in HIV and immunosuppression. Clinics in Dermatology 38:1, pages 52-62.
Crossref
Crossref
Hakan Guvenir, Tugba Arikoglu, Emine Vezir & Emine Dibek Misirlioglu. (2019) Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions. Current Pharmaceutical Design 25:36, pages 3840-3854.
Crossref
Crossref
Osward Y. Carrasquillo, Marely Santiago‐Vazquez, Rocio Cardona, Mariana Cruz‐Manzano & Luz D. Figueroa. (2019) Stevens‐Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. International Journal of Dermatology 58:11, pages 1293-1299.
Crossref
Crossref
Tae-Ok Kim, Hong-Joon Shin, Yu-Il Kim, Sung-Chul Lim, Young-Il Koh & Yong-Soo Kwon. (2019) Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment. The Korean Journal of Internal Medicine 34:5, pages 1050-1057.
Crossref
Crossref
Lor Huai Chong, Celine Ng, Huan Li, Edmund Feng Tian, Abhishek Ananthanarayanan, Michael McMillian & Yi-Chin Toh. (2019) Hepatic Bioactivation of Skin-Sensitizing Drugs to Immunogenic Reactive Metabolites. ACS Omega 4:9, pages 13902-13912.
Crossref
Crossref
M Carrozzo, J Grau Eriksen, R -J Bensadoun, C B Boers-Doets, R V Lalla & D E Peterson. (2019) Oral Mucosal Injury Caused by Targeted Cancer Therapies. JNCI Monographs 2019:53.
Crossref
Crossref
Kojiro Morita, Hiroki Matsui, Nobuaki Michihata, Kiyohide Fushimi & Hideo Yasunaga. (2019) Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database. American Journal of Clinical Dermatology 20:4, pages 579-592.
Crossref
Crossref
Kellie J. Goodlet, Monika T. Zmarlicka & Alyssa M. Peckham. (2018) Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs. CNS Spectrums 24:03, pages 287-312.
Crossref
Crossref
Eva Potocnik, Karolina Drozdzewska & Bianca Schwarz. (2019) Presumed Sulfonamide-Associated Uveitis With Stevens-Johnson Syndrome in a Quarter Horse Mare. Journal of Equine Veterinary Science 77, pages 17-22.
Crossref
Crossref
Guillaume Chaby, Saskia Ingen-Housz-Oro, Nicolas De Prost, Pierre Wolkenstein, Olivier Chosidow & Laurence Fardet. (2019) Idiopathic Stevens-Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics. Journal of the American Academy of Dermatology 80:5, pages 1453-1455.
Crossref
Crossref
Mohammad Shariq Mukarram. (2019) Systemic lupus erythematosus presenting as stevens johnson syndrome in a thirty years old female: a case report. Journal of Lung, Pulmonary & Respiratory Research 6:1, pages 20-21.
Crossref
Crossref
Cynthia X. Wang, Milan J. Anadkat & Amy C. Musiek. (2018) Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients. American Journal of Clinical Dermatology 20:1, pages 55-73.
Crossref
Crossref
Rohit Agrawal, Anas Almoghrabi, Bashar M. Attar & Seema Gandhi. (2019) Fluoxetine-induced Stevens-Johnson syndrome and liver injury. Journal of Clinical Pharmacy and Therapeutics 44:1, pages 115-118.
Crossref
Crossref
Hea Lin Oh, Dong Yoon Kang, Hye-Ryun Kang, Sujeong Kim, Young-Il Koh, Sae Hoon Kim, Min-Hye Kim & Dong In Suh. (2019) Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry. Allergy, Asthma & Immunology Research 11:2, pages 241.
Crossref
Crossref
Amanda Leal Rocha, Alessandra Figueiredo De Souza, Laiz Fernandes Mendes Nunes, Nayara Dias de Souza Cunha, Célia Regina Moreira Lanza, Denise Vieira Travassos & Tarcília Aparecida da Silva. (2018) Treatment of oral manifestations of toxic epidermal necrolysis with low‐level laser therapy in a pediatric patient. Pediatric Dermatology 36:1.
Crossref
Crossref
Ze-Hu Liu & Hong Shen. (2019) Mycoplasma-Induced Toxic Epidermal Necrolysis with Severe Mucositis. The Journal of Allergy and Clinical Immunology: In Practice 7:1, pages 286-287.
Crossref
Crossref
James W. Antoon, Jennifer L. Goldman, Samir S. Shah & Brian Lee. (2019) A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. The Journal of Allergy and Clinical Immunology: In Practice 7:1, pages 244-250.e1.
Crossref
Crossref
B. Azzena, C. Tiengo, G. Giatsidis, R. Salmaso & A. Pontini. (2018) Treatment of a Severe Pediatric Lyell Syndrome with Amniotic Membrane: Case Report and Histological Findings. Journal of Tissue Repair and Regeneration 1:2, pages 12-21.
Crossref
Crossref
Xavier Tchetnya, Calypse Asangbe Ngwasiri, Tiayah Munge & Leopold Ndemnge Aminde. (2018) Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon. BMC Pediatrics 18:1.
Crossref
Crossref
Tao Han Lee, Cheng-Chia Lee, Chau-Yee Ng, Ming-Yang Chang, Su-Wei Chang, Pei-Chun Fan, Wen-Hung Chung, Ya-Chung Tian, Yung-Chang Chen & Chih-Hsiang Chang. (2018) The influence of acute kidney injury on the outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging. PLOS ONE 13:9, pages e0203642.
Crossref
Crossref
Jae-Woo Jung, Jae-Yeol Kim, In-Won Park, Byoung-Whui Choi & Hye-Ryun Kang. (2018) Genetic markers of severe cutaneous adverse reactions. The Korean Journal of Internal Medicine 33:5, pages 867-875.
Crossref
Crossref
Passara Jongkhajornpong, Kaevalin Lekhanont, Phattrawan Pisuchpen, Patchima Chantaren, Vilavun Puangsricharern, Pinnita Prabhasawat, Kanya Suphapeetiporn, Shigeru Kinoshita & Mayumi Ueta. (2018) Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. British Journal of Ophthalmology 102:9, pages 1303-1307.
Crossref
Crossref
Forson Chan, Matthew D. Benson, David J.A. Plemel, Muhammad N. Mahmood & Stanley M. Chan. (2018) A diagnosis of Stevens-Johnson Syndrome (SJS) in a patient presenting with superficial keratitis. American Journal of Ophthalmology Case Reports 11, pages 167-169.
Crossref
Crossref
Wendy C. Fang, Nikki R. Adler, Linda V. Graudins, Caitlin Goldblatt, Michelle S. Y. Goh, Stuart K. Roberts, Jason A. Trubiano & Ar Kar Aung. (2018) Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals. Internal Medicine Journal 48:5, pages 549-555.
Crossref
Crossref
Alexander K. C. Leung, Benjamin Barankin & Kin Fon Leong. (2018) Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management. World Journal of Pediatrics 14:2, pages 116-120.
Crossref
Crossref
Eccard da Silva Ricardo, Garbi Novaes Alice, Bernarda Donato Göttems Leila & Rita Carvalho Garbi Novaes Maria. (2018) Risk factors for, and treatment of, Stevens-Johnson syndrome and toxic epidermal necrolysis: Evidence from the literature. African Journal of Pharmacy and Pharmacology 12:4, pages 61-70.
Crossref
Crossref
Shang-Chen Yang, Sindy Hu, Sheng-Zheng Zhang, Jin-wen Huang, Jing Zhang, Chao Ji & Bo Cheng. (2018) The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China. Journal of Immunology Research 2018, pages 1-10.
Crossref
Crossref
Gwendolin Simper, Alexander A. Celik, Heike Kunze-Schumacher, Rainer Blasczyk & Christina Bade-Döding. 2017. Physiology and Pathology of Immunology. Physiology and Pathology of Immunology.
Takuya Imatoh, Kimie Sai, Chisato Fukazawa, Yasushi Hinomura, Ryosuke Nakamura, Yoshimi Okamoto-Uchida, Katsunori Segawa & Yoshiro Saito. (2017) Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database. European Journal of Clinical Pharmacology 73:12, pages 1643-1653.
Crossref
Crossref
N.R. Adler, A.K. Aung, E.N. Ergen, J. Trubiano, M.S.Y. Goh & E.J. Phillips. (2017) Recent advances in the understanding of severe cutaneous adverse reactions. British Journal of Dermatology 177:5, pages 1234-1247.
Crossref
Crossref
Simone Negrini & Laurent Becquemont. (2017) HLA-associated drug hypersensitivity and the prediction of adverse drug reactions. Pharmacogenomics 18:15, pages 1441-1457.
Crossref
Crossref
Luana Bernardes Arantes, Carmélia Santiago Reis, Alice Garbi Novaes, Marta Rodrigues de Carvalho, Leila Bernarda Donato Göttems & Maria Rita Carvalho Garbi Novaes. (2017) Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals. Anais Brasileiros de Dermatologia 92:5, pages 661-667.
Crossref
Crossref
A.-P. Villani, M. Vocanson, L. Laoubi, D. Jullien, F. Bérard, J.-F. Nicolas & B. Bensaid. (2017) Nécrolyse épidermique toxique : physiopathologie et avancées thérapeutiques. Revue Française d'Allergologie 57:6, pages 418-425.
Crossref
Crossref
Tanja G. Bohl. (2017) Fissures, Herpes Simplex Virus, and Drug Reactions. Obstetrics and Gynecology Clinics of North America 44:3, pages 421-443.
Crossref
Crossref
Oluwaseun Egunsola, Kristina Star, Kristina Juhlin, Sylvia H Kardaun, Imti Choonara & Helen M Sammons. (2017) Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database. BMJ Paediatrics Open 1:1, pages e000039.
Crossref
Crossref
Elham E. Bukhari, Fawzia E. Alotaibi, Amani S. Bugshan, Hind M. Bakheet, Salman M. Binsufayan & Muslim M. Alsaadi. (2017) Mycoplasma pneumoniae- associated mucositis syndrome: A rare and clinically challenging disease in a Saudi child. Journal of Taibah University Medical Sciences 12:4, pages 356-359.
Crossref
Crossref
Robert Cartotto. (2017) Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinics in Plastic Surgery 44:3, pages 583-595.
Crossref
Crossref
A. Combalia, N. Moreno, P. Iranzo, M. Tuset & J.-M. Mascar?. (2017) Stevens-Johnson syndrome probably induced by ambroxol. Clinical and Experimental Dermatology 42:4, pages 465-467.
Crossref
Crossref
Xingang Li, Zhigang Zhao & Shu-Sen Sun. (2017) Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis. American Journal of Health-System Pharmacy 74:9, pages e183-e192.
Crossref
Crossref
M. Arenbergerova, I. Mrazova, J. Horazdovsky, E. Sticova, A. Fialova & P. Arenberger. (2017) Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure. Journal of the European Academy of Dermatology and Venereology 31:5, pages e253-e254.
Crossref
Crossref
Maren Paulmann & Maja Mockenhaupt. (2017) Fever in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases. Pediatric Infectious Disease Journal 36:5, pages 513-515.
Crossref
Crossref
Jonathan Grant Peter, Rannakoe Lehloenya, Sipho Dlamini, Kimberly Risma, Katie D. White, Katherine C. Konvinse & Elizabeth J. Phillips. (2017) Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice 5:3, pages 547-563.
Crossref
Crossref
Simone Negrini & Laurent Becquemont. (2017) Pharmacogenetics of hypersensitivity drug reactions. Therapies 72:2, pages 231-243.
Crossref
Crossref
Zachary Seagrave & Sonya Bamba. (2017) Adverse drug reactions. Disease-a-Month 63:2, pages 49-53.
Crossref
Crossref
A.L. Melikyan, Irina Nikolaevna Subortseva, A.M. Kovrigina, T.I. Kolosheinova, E.K. Egorova & E.I. Pustovaya. (2017) Stevens-Johnson Syndrome after Treatment of Female Patient with Small Lymphocytic B-Cell Lymphoma, Autoimmune Hemolytic Anemia and Antiphospholipid Antibody Syndrome with Rituximab. Clinical oncohematology 10:1, pages 120-127.
Crossref
Crossref
Yuri Kinoshita & Hidehisa Saeki. (2017) A Review of the Active Treatments for Toxic Epidermal Necrolysis. Journal of Nippon Medical School 84:3, pages 110-117.
Crossref
Crossref
Passara Jongkhajornpong, Kaevalin Lekhanont, Sukanya Siriyotha, Silada Kanokrungsee & Varintorn Chuckpaiwong. (2017) Factors Contributing to Long-Term Severe Visual Impairment in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Journal of Ophthalmology 2017, pages 1-7.
Crossref
Crossref
Yuri Kinoshita & Hidehisa Saeki. (2017) A review of toxic epidermal necrolysis management in Japan. Allergology International 66:1, pages 36-41.
Crossref
Crossref
Roni P. Dodiuk-Gad, Wen-Hung Chung & Neil H. Shear. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
439
467
.
Akintunde Alabi, Adam Todd, Andrew Husband & Joe Reilly. (2016) Safety profile of lamotrigine in overdose. Therapeutic Advances in Psychopharmacology 6:6, pages 369-381.
Crossref
Crossref
Min-Suk Yang, Jin Yong Lee, Jayeun Kim, Gun-Woo Kim, Byung-Keun Kim, Ju-Young Kim, Heung-Woo Park, Sang-Heon Cho, Kyung-Up Min & Hye-Ryun Kang. (2016) Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLOS ONE 11:11, pages e0165933.
Crossref
Crossref
Thavenesh K Ramachandren & Renée MA Petrilli. (2016) Early toxic epidermal necrolysis syndrome post-intra-cranial tumor resection. Scottish Medical Journal 61:4, pages 200-202.
Crossref
Crossref
Jason A. Trubiano, Ar Kar Aung, Mary Nguyen, Sasha R. Fehily, Linda Graudins, Heather Cleland, Alex Padiglione & Anton Y. Peleg. (2016) A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions. The Journal of Allergy and Clinical Immunology: In Practice 4:6, pages 1187-1193.
Crossref
Crossref
Takashi Watari, Shuku Sato, Haruki Uojima & Yasuharu Tokuda. (2016) Successful Combination Therapy Including Plasma Exchange for Severe Toxic Epidermal Necrolysis. Journal of General and Family Medicine 17:3, pages 232-237.
Crossref
Crossref
. (2016) Stevens–Johnson syndrome and toxic epidermal necrolysis: early recognition and prompt management may reduce mortality. Drugs & Therapy Perspectives 32:6, pages 238-243.
Crossref
Crossref
Richard A. Thompson, Emre M. Isin, Monday O. Ogese, Jerome T. Mettetal & Dominic P. Williams. (2016) Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chemical Research in Toxicology 29:4, pages 505-533.
Crossref
Crossref
Zhibin ChenDanny LiewPatrick Kwan. (2016) Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment. Neurology 86:12, pages 1086-1094.
Crossref
Crossref
Thomas M. Nappe, Stephanie L. Goren-Garcia & Jeanne L. Jacoby. (2016) Stevens-Johnson syndrome after treatment with azithromycin: an uncommon culprit. The American Journal of Emergency Medicine 34:3, pages 676.e1-676.e3.
Crossref
Crossref
Janouk Diphoorn, Simone Cazzaniga, Chiara Gamba, Jan Schroeder, Antonella Citterio, Alma Lisa Rivolta, Giuseppe Danilo Vighi & Luigi Naldi. (2016) Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiology and Drug Safety 25:2, pages 196-203.
Crossref
Crossref
Ga-Young BanSeun-Joo AhnHye-Soo YooHae-Sim ParkYoung-Min Ye. (2016) Stevens?Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections. Immune Network 16:4, pages 256.
Crossref
Crossref
Roberta Sartori & Silvia Colombo. (2016) Stevens–Johnson syndrome/toxic epidermal necrolysis caused by cefadroxil in a cat. Journal of Feline Medicine and Surgery Open Reports 2:1, pages 205511691665361.
Crossref
Crossref
Sergey Zakharov, Jan Csomor, Petr Urbanek & Daniela Pelclova. (2016) Toxic Epidermal Necrolysis After Exposure to Dithiocarbamate Fungicide Mancozeb. Basic & Clinical Pharmacology & Toxicology 118:1, pages 87-91.
Crossref
Crossref
Byeong Soo Kang, Mee Kum Kim, Won Ryang Wee & Joo Youn Oh. (2016) Infectious Keratitis in Limbal Stem Cell Deficiency. Cornea 35:1, pages 51-55.
Crossref
Crossref
Sahar Kohanim, Sotiria Palioura, Hajirah N. Saeed, Esen K. Akpek, Guillermo Amescua, Sayan Basu, Preston H. Blomquist, Charles S. Bouchard, John K. Dart, Xiaowu Gai, Jos? A.P. Gomes, Darren G. Gregory, Geetha Iyer, Deborah S. Jacobs, Anthony J. Johnson, Shigeru Kinoshita, Iason S. Mantagos, Jodhbir S. Mehta, Victor L. Perez, Stephen C. Pflugfelder, Virender S. Sangwan, Kimberly C. Sippel, Chie Sotozono, Bhaskar Srinivasan, Donald T.H. Tan, Radhika Tandon, Scheffer C.G. Tseng, Mayumi Ueta & James Chodosh. (2016) Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis ? A Comprehensive Review and Guide to Therapy. I. Systemic Disease. The Ocular Surface 14:1, pages 2-19.
Crossref
Crossref
Maja Mockenhaupt. 2016. Verbrennungschirurgie. Verbrennungschirurgie
403
416
.
Maja Mockenhaupt. 2016. Verbrennungschirurgie. Verbrennungschirurgie
389
401
.
Dennis A. Smith. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry
128
157
.
I.M.M.H. Oen, C.H. van der Vlies, Y.W.F. Roeleveld, J. Dokter, M.J. Hop & M.E. van Baar. (2015) Epidemiology and costs of patients with toxic epidermal necrolysis: a 27‐year retrospective study. Journal of the European Academy of Dermatology and Venereology 29:12, pages 2444-2450.
Crossref
Crossref
Sabyasachi Paik, Agnik Pal, Sukanta Sen, Netai Pramanick & Santanu K. Tripathi. (2015) A Suspected Case of Efavirenz-Induced Stevens?Johnson Syndrome. Drug Safety - Case Reports 2:1.
Crossref
Crossref
Roni P. Dodiuk-Gad, Wen-Hung Chung, Laurence Valeyrie-Allanore & Neil H. Shear. (2015) Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update. American Journal of Clinical Dermatology 16:6, pages 475-493.
Crossref
Crossref
Jesse Szatkowski & Robert A. Schwartz. (2015) Acute generalized exanthematous pustulosis (AGEP): A review and update. Journal of the American Academy of Dermatology 73:5, pages 843-848.
Crossref
Crossref
Mayson B. Mustafa, Stephen R. Porter, Bruce R. Smoller & Cassian Sitaru. (2015) Oral mucosal manifestations of autoimmune skin diseases. Autoimmunity Reviews 14:10, pages 930-951.
Crossref
Crossref
Razvigor Darlenski, Jana Kazandjieva & Nikolai Tsankov. (2015) Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS. Clinics in Dermatology 33:5, pages 538-541.
Crossref
Crossref
HIROSHI CHANTAPHAKUL, THANOMSAK SANON & JETTANONG KLAEWSONGKRAM. (2015) Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Experimental and Therapeutic Medicine 10:2, pages 519-524.
Crossref
Crossref
Jovan Lalosevic, Milos Nikolic, Mirjana Gajic-Veljic, Dusan Skiljevic & Ljiljana Medenica. (2015) Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. International Journal of Dermatology 54:8, pages 978-984.
Crossref
Crossref
Elisa Mart?n-Merino, Francisco J. de Abajo & Miguel Gil. (2015) Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. European Journal of Clinical Pharmacology 71:6, pages 759-766.
Crossref
Crossref
Praveena Gungam, Pruthvi Desireddy, Balakrishna Namala & Souris Kondaveti. (2015) ACYCLOVIR INDUCED STEVEN JOHNSON SYNDROME. Journal of Evidence Based Medicine and Healthcare 2:15, pages 2363-2366.
Crossref
Crossref
Antonio Bascones-Martínez, Virginia García-García, Jukka H. Meurman & Luis Requena-Caballero. (2015) Immune-mediated diseases: what can be found in the oral cavity?. International Journal of Dermatology 54:3, pages 258-270.
Crossref
Crossref
E. Cinotti & F. Cambazard. (2015) Dermatosis ampollosas de la infancia. EMC - Pediatr?a 50:1, pages 1-13.
Crossref
Crossref
Jacob S Heng, Nabeel Malik, Naresh Joshi, Michelle Hayes, Isabel Jones, L Claire Fuller & Marcela P Vizcaychipi. (2015) Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients. British Journal of Ophthalmology 99:2, pages 251-254.
Crossref
Crossref
Melissa A. Martinez, Raj Vuppalanchi, Robert J. Fontana, Andrew Stolz, David E. Kleiner, Paul H. Hayashi, Jiezhun Gu, Jay H. Hoofnagle & Naga Chalasani. (2015) Clinical and Histologic Features of Azithromycin-Induced Liver Injury. Clinical Gastroenterology and Hepatology 13:2, pages 369-376.e3.
Crossref
Crossref
Maria Ilaria Del Principe, Giuseppe Sconocchia, Francesco Buccisano, Mariagiovanna Cefalo, Ambra Di Veroli, Giovanna De Santis, Daniela Nasso, Luca Maurillo, Lucia Anemona, Massimiliano Postorino, Giovanni Del Poeta, Sergio Amadori & Adriano Venditti. (2014) Extensive toxic epidermal necrolysis following brentuximab vedotin administration. Annals of Hematology 94:2, pages 355-356.
Crossref
Crossref
Hong Ki MinBoin LeeSeung-Ki KwokJi Hyeon JuWan-Uk KimYoung Min ParkSung-Hwan Park. (2015) Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. The Korean Journal of Internal Medicine 30:4, pages 521.
Crossref
Crossref
Elizabeth Jones, Megan Stair-Buchmann, Sophia Kotliar & Linwood Haith. (2015) Purpura Fulminans in Toxic Epidermal Necrolysis. Journal of Burn Care & Research 36:6, pages e274-e282.
Crossref
Crossref
David J. Weber, Myron S. Cohen & William A. Rutala. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
732
747.e4
.
Hye Jung Park, Sung Ryeol Kim, Dong Woo Leem, Il Joo Moon, Beom Seok Koh, Kyung Hee Park, Jung-Won Park & Jae-Hyun Lee. (2014) Clinical features of and genetic predisposition to drug-induced Stevens?Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients?investigating the relation between the HLA -B*4403 allele and lamotrigine. European Journal of Clinical Pharmacology 71:1, pages 35-41.
Crossref
Crossref
Matthew J. Weiss & Victor L. Perez. 2015. Keratoprostheses and Artificial Corneas. Keratoprostheses and Artificial Corneas
137
144
.
Zhi-Dan Fan, Xiao-Qing Qian & Hai-Guo Yu. (2014) Pancytopenia as an early indicator for Stevens-Johnson syndrome complicated with hemophagocytic lymphohistiocytosis: a case report. BMC Pediatrics 14:1.
Crossref
Crossref
Patrick D. Mahar, Jason Wasiak, Eldho Paul, David A. Watters, Julia Kirby, Douglas Gin, Philip Marsh & Heather Cleland. (2014) Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre. Burns 40:8, pages 1743-1747.
Crossref
Crossref
Julie A. Yager. (2014) Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis: a comparative review. Veterinary Dermatology 25:5, pages 406.
Crossref
Crossref
Ioannis G. Koutlas. (2014) Syndromes Affecting Skin and Mucosa. Atlas of the Oral and Maxillofacial Surgery Clinics 22:2, pages 135-151.
Crossref
Crossref
James R. Perkins, Pedro Ayuso, José A. Cornejo-García & Juan A. Ranea. (2014) The study of severe cutaneous drug hypersensitivity reactions from a systems biology perspective. Current Opinion in Allergy & Clinical Immunology 14:4, pages 301-306.
Crossref
Crossref
Jeffrey M. Hotaling & Andrew J. Hotaling. (2014) Otologic complications of Stevens?Johnson Syndrome and Toxic Epidermal Necrolysis. International Journal of Pediatric Otorhinolaryngology 78:8, pages 1408-1409.
Crossref
Crossref
Andrew J. Bishop, Maria Chang, Mario E. Lacouture & Christopher A. Barker. (2014) EMPACT syndrome: limited evidence despite a high-risk cohort. Journal of Neuro-Oncology 119:1, pages 129-134.
Crossref
Crossref
T. Ishida, Y. Kano, Y. Mizukawa & T. Shiohara. (2014) The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome. Allergy 69:6, pages 798-805.
Crossref
Crossref
Chao Yang, Anisa Mosam, Avumile Mankahla, Ncoza Dlova & Arturo Saavedra. (2014) HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. Journal of the American Academy of Dermatology 70:6, pages 1096-1102.
Crossref
Crossref
C.-Y. Yang, C.-H. Chen, H.-Y. Wang, H.-L. Hsiao, Y.-H. Hsiao & W.-H. Chung. (2014) Strontium ranelate related Stevens–Johnson syndrome: a case report. Osteoporosis International 25:6, pages 1813-1816.
Crossref
Crossref
Ursula Amstutz, Neil H. Shear, Michael J. Rieder, Soomi Hwang, Vincent Fung, Hidefumi Nakamura, Mary B. Connolly, Shinya Ito & Bruce C. Carleton. (2014) Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia 55:4, pages 496-506.
Crossref
Crossref
P. Demoly, N. F. Adkinson, K. Brockow, M. Castells, A. M. Chiriac, P. A. Greenberger, D. A. Khan, D. M. Lang, H.-S. Park, W. Pichler, M. Sanchez-Borges, T. Shiohara & B. Y.-H. Thong. (2014) International Consensus on drug allergy. Allergy 69:4, pages 420-437.
Crossref
Crossref
Rannakoe J. Lehloenya & Mahlatse Kgokolo. (2014) Clinical Presentations of Severe Cutaneous Drug Reactions in HIV-Infected Africans. Dermatologic Clinics 32:2, pages 227-235.
Crossref
Crossref
Eun-Jin KimHyun LimSo Young ParkSujeong KimSun-Young YoonYun-Jeong BaeHyouk-Soo KwonYou Sook ChoHee-Bom MoonTae-Bum Kim. (2014) Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pacific Allergy 4:1, pages 68.
Crossref
Crossref
Mi-Yeong KimMin-Suk YangHye-Ryun KangSang-Heon ChoKyung-Up Min. (2014) Analysis of Drugs Causing Severe Cutaneous Adverse Reactions, Based on the Korean Database of Spontaneously Reported Adverse Drug Reactions. Korean Journal of Medicine 86:6, pages 710.
Crossref
Crossref
Seung Jin LeeBong Hwa KangMin Hyun Cho. (2014) Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome. Journal of the Korean Society of Pediatric Nephrology 18:2, pages 123.
Crossref
Crossref
Anne Isvy-Joubert, Saskia Ingen-Housz-Oro, Renaud Vincent, Cynthia Haddad, Laurence Valeyrie-Allanore, Olivier Chosidow, Jean-Michel Race & Pierre Wolkenstein. (2014) Severe Cutaneous Adverse Reactions to Drugs: From Patients to the National Office for Compensation of Medical Accidents. Dermatology 228:4, pages 338-343.
Crossref
Crossref
Sandosh Padmanabhan. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
3
25
.
Argyrios Chronopoulos, Tina Dietrich-Ntoukas, Arnd Heiligenhaus, Carsten Heinz, Elisabeth M. Messmer, Maja Mockenhaupt, Uwe Pleyer, Anne Rübsam & Juliane Schlomberg. 2014. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen
117
180
.
Ellen K. Roh, Ruth Ann Vleugels & Mai P. Hoang. (2013) Case 39-2013. New England Journal of Medicine 369:25, pages 2438-2449.
Crossref
Crossref
Wen-Hung Chung, Shin-Ru Shih, Ching-Fen Chang, Tzou-Yien Lin, Yhu-Chering Huang, Shih-Chen Chang, Ming-Tsan Liu, Yu-Shien Ko, Ming-Chung Deng, Yea-Ling Liau, Lung-Huang Lin, Tou-Hwei Chen, Chih-Hsun Yang, Hsin-Chun Ho, Jheng-Wei Lin, Chun-Wei Lu, Chin-Fang Lu & Shuen-Iu Hung. (2013) Clinicopathologic Analysis of Coxsackievirus A6 New Variant Induced Widespread Mucocutaneous Bullous Reactions Mimicking Severe Cutaneous Adverse Reactions. The Journal of Infectious Diseases 208:12, pages 1968-1978.
Crossref
Crossref
Justin P Dassie & Paloma H Giangrande. (2013) Current progress on aptamer-targeted oligonucleotide therapeutics. Therapeutic Delivery 4:12, pages 1527-1546.
Crossref
Crossref
Carla Ferrandiz-Pulido & Vicente Garcia-Patos. (2013) A review of causes of Stevens–Johnson syndrome and toxic epidermal necrolysis in children. Archives of Disease in Childhood 98:12, pages 998-1003.
Crossref
Crossref
Marina Atanaskovi?-Markovi?, Biljana Medjo, Marija Gavrovi?-Jankulovi?, Tanja ?irkovi? Veli?kovi?, Dimitrije Nikoli? & Branimir Nestorovi?. (2013) Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatric Allergy and Immunology 24:7, pages 645-649.
Crossref
Crossref
C. Weinand, W. Xu, W. Perbix, R. Lefering, M. Maegele, M. Rathert & G. Spilker. (2013) 27 years of a single burn centre experience with Stevens?Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality risk for causative agents. Burns 39:7, pages 1449-1455.
Crossref
Crossref
Cinzia Ciccacci, Davide Di Fusco, Maria C. Marazzi, Ines Zimba, Fulvio Erba, Giuseppe Novelli, Leonardo Palombi, Paola Borgiani & Giuseppe Liotta. (2013) Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study. European Journal of Clinical Pharmacology 69:11, pages 1909-1916.
Crossref
Crossref
Julie M. Schallhorn & John Gonzales. (2013) Ocular toxoplasmosis: the treatment dilemma. Journal of American Association for Pediatric Ophthalmology and Strabismus 17:5, pages 454-455.
Crossref
Crossref
Chuang-Wei Wang, Wen-Hung Chung, Yi-Fang Cheng, Nien-Wen Ying, Konan Peck, Yuan-Tsong Chen & Shuen-Iu Hung. (2013) A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders. Journal of Allergy and Clinical Immunology 132:3, pages 713-722.e11.
Crossref
Crossref
Robert A. Schwartz, Patrick H. McDonough & Brian W. Lee. (2013) Toxic epidermal necrolysis. Journal of the American Academy of Dermatology 69:2, pages 173.e1-173.e13.
Crossref
Crossref
Cynthia Haddad, Alexis Sidoroff, Sylvia H. Kardaun, Maja Mockenhaupt, Daniel Creamer, Ariane Dunant & Jean-Claude Roujeau. (2013) Stevens?Johnson Syndrome/Toxic Epidermal Necrolysis: Are Drug Dictionaries Correctly Informing Physicians Regarding the Risk?. Drug Safety 36:8, pages 681-686.
Crossref
Crossref
U Amstutz, C J D Ross, L I Castro-Pastrana, M J Rieder, N H Shear, M R Hayden & B C Carleton. (2013) HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children. Clinical Pharmacology & Therapeutics 94:1, pages 142-149.
Crossref
Crossref
Aneesh S. Patel, Elisa M. Supan & Shereef N. Ali. (2013) Toxic epidermal necrolysis associated with rifaximin. American Journal of Health-System Pharmacy 70:10, pages 874-876.
Crossref
Crossref
Lisa Byrom, Tania Zappala & Jim Muir. (2013) Toxic epidermal necrolysis caused by over the counter eyedrops. Australasian Journal of Dermatology 54:2, pages 144-146.
Crossref
Crossref
Jeannette Y. Wick. (2013) Drug-Induced Rash: Nuisance or Threat?. The Consultant Pharmacist 28:3, pages 160-166.
Crossref
Crossref
Yuichi Teraki, Misaki Kawabe & Seiichi Izaki. (2013) Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. Journal of Allergy and Clinical Immunology 131:3, pages 907-909.
Crossref
Crossref
F. Brunet-Possenti, M. Steff, E. Marinho, B. Crickx & V. Descamps. (2013) Syndrome de Stevens-Johnson au cours d?une primo-infection par le virus d?Epstein-Barr. Annales de Dermatologie et de V?n?r?ologie 140:2, pages 112-115.
Crossref
Crossref
Bernard Yu-Hor Thong. (2013) Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective. Asia Pacific Allergy 3:4, pages 215.
Crossref
Crossref
Jae Ho LeeIl Nam JuHyung Jun ChoHong Ki MinYeon-Sik Hong. (2013) Toxic Epidermal Necrolysis by Ceftriaxone in Patient with Newly Diagnosed Systemic Lupus Erythematosus. Journal of Rheumatic Diseases 20:6, pages 374.
Crossref
Crossref
Patrick D. Mahar, Jason Wasiak, Heather Cleland, David Watters, Eldho Paul, Philip Marsh & Douglas Gin. (2013) Mortality and Use of the Auxiliary Score in Extensive Toxic Epidermal Necrolysis Patients Admitted to an Adult Burns Referral Centre. Dermatology 227:2, pages 180-185.
Crossref
Crossref
G. E. Piérard, T. Hermanns-Lê, P. Paquet, A. F. Rousseau, P. Delvenne & C. Piérard-Franchimont. (2013) Toxic Epidermal Necrolysis and Graft-versus-Host Reaction: Revisiting a Puzzling Similarity. ISRN Dermatology 2013, pages 1-6.
Crossref
Crossref
Ana Carolina Vieira & Mark J. Mannis. 2013. Ocular Surface Disease: Cornea, Conjunctiva and Tear Film. Ocular Surface Disease: Cornea, Conjunctiva and Tear Film
171
178
.
Tamer Kamal, Sherif Elnikety, Heba Mashaly & James Casha. (2012) Acute compartment syndrome of the forearm as a rare complication of toxic epidermal necrolysis: a case report. Journal of Medical Case Reports 6:1.
Crossref
Crossref
Paloma Borreg?n Nofuentes & Ricardo Su?rez Fern?ndez. (2012) Urgencias en Dermatolog?a. Piel 27:10, pages 570-580.
Crossref
Crossref
Li-Yen Huang, Chih-Ming Lin, Chien-Chun Chiou, Wei-Shiang Lin & Shu-Meng Cheng. (2012) Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis. Clinical Biochemistry 45:16-17, pages 1531-1532.
Crossref
Crossref
David R. Minor, Robert Rodvien & Mohammed Kashani-Sabet. (2012) Successful desensitization in a case of Stevens–Johnson syndrome due to vemurafenib. Melanoma Research 22:5, pages 410-411.
Crossref
Crossref
H.Y. Lee, A. Dunant, P. Sekula, M. Mockenhaupt, P. Wolkenstein, L. Valeyrie-Allanore, L. Naldi, S. Halevy & J.C. Roujeau. (2012) The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies. British Journal of Dermatology 167:3, pages 555-562.
Crossref
Crossref
C. Marks & R. Marks. (2012) Intensivpflichtige HauterkrankungenDermatological conditions requiring intensive care. Der Hautarzt 63:9, pages 727-738.
Crossref
Crossref
M. Ziemer, S.H. Kardaun, Y. Liss & M. Mockenhaupt. (2012) Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. British Journal of Dermatology 166:3, pages 575-600.
Crossref
Crossref
Hye-In KimShin-Woo KimGa-Young ParkEu-Gene KwonHyo-Hoon KimJu-Young JeongHyun-Ha ChangJong-Myung LeeNeung-Su Kim. (2012) Causes and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients. The Korean Journal of Internal Medicine 27:2, pages 203.
Crossref
Crossref